Tumor antigens and DC, obtained by surgical resection and leukapheresis, respectively, DCs are mixed and injected back to the patient, allowing DCs to present their surface tumor antigens to the CD4 and CD8 T-cells of the immune system, leading to the activation of T-cells against the tumor. Here, CD4 is linked to neoplasm.